Impel Pharmaceuticals Inc. (IMPL) NASDAQ

$0.24 - (-)

Market Cap: -

As of 12/15/23 12:00 AM EST. Market closed.

(IMPL)

Impel Pharmaceuticals Inc. (IMPL)
NASDAQ

$0.24
- (-)

Market Cap: -

As of 12/15/23 12:00 AM EST. Market closed.

Add to Portfolio

impel neuropharma, inc., is a privately-held, seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (cns) diseases. impel's products are based on a novel nasal drug delivery platform, the pod™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner. impel neuropharma is currently investigating inp104 ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
201 ELLIOTT AVE. W, SUITE 260, Washington, Seattle, 98119.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Michael Hite
Address
201 ELLIOTT AVE. W, SUITE 260, Washington, Seattle, 98119.
PRICE CHART FOR IMPEL PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.39
Previous Close
$0.24
Days Range
$0.23 - $0.44
52 week range
- - -
Volume
858,521
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
23,900,031
Open
$0.39
Previous Close
$0.24
Days Range
$0.23 - $0.44
52 week range
- - -
Volume
858,521
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
23,900,031
FINANCIAL STATEMENTS FOR IMPEL PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IMPEL PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Vivo Capital VIII, LLC10% OwnerDec 19, 2023 Sale$0.0828,6322,291280,294Dec 19, 2023, 06:00 PM
Vivo Capital VIII, LLC10% OwnerDec 19, 2023 Sale$0.08208,65716,6932,029,495Dec 19, 2023, 06:00 PM
Vivo Capital VIII, LLC10% OwnerDec 18, 2023 Sale$0.1128,6823,155308,926Dec 19, 2023, 06:00 PM
Vivo Capital VIII, LLC10% OwnerDec 18, 2023 Sale$0.11209,02922,9932,238,152Dec 19, 2023, 06:00 PM
Vivo Capital VIII, LLC10% OwnerDec 15, 2023 Sale$0.2912,0663,499337,608Dec 19, 2023, 06:00 PM
Vivo Capital VIII, LLC10% OwnerDec 15, 2023 Sale$0.2987,93425,5012,447,181Dec 19, 2023, 06:00 PM
Leaman John HaroldChief Fin. & Business OfficerDec 31, 2022 Option Exercise$3.753,62713,6016,944Jan 04, 2023, 06:46 PM
SHREWSBURY STEPHEN BChief Medical OfficerMar 29, 2022 Option Exercise$1.9724,60648,47497,990Mar 30, 2022, 09:54 PM
Hoekman JohnChief Scientific OfficerDec 22, 2021 Option Exercise$1.6420,00032,800128,221Dec 23, 2021, 04:50 PM
NELSON TIMOTHY SDirectorNov 19, 2021 Buy$10.7610,000107,55410,000Nov 22, 2021, 05:05 PM
SHREWSBURY STEPHEN BChief Medical OfficerSep 21, 2021 Option Exercise$2.7273,384199,72073,384Sep 22, 2021, 04:57 PM
ADAMS ADRIANCOB, CEO and PresidentAug 18, 2021 Buy$13.9920,000279,79020,000Aug 19, 2021, 05:23 PM
Vivo Capital VIII, LLC10% OwnerApr 27, 2021 Option Exercise$13.50101,4561,369,6562,029,495Apr 29, 2021, 09:10 PM
Vivo Capital VIII, LLC10% OwnerApr 27, 2021 Buy$15.00575,0008,625,0002,535,115Apr 29, 2021, 09:10 PM
venBio Global Strategic Fund II L.P.10% OwnerApr 27, 2021 Buy$15.00450,0006,750,0002,759,791Apr 29, 2021, 06:44 PM
PARKER H STEWARTDirectorApr 27, 2021 Option Exercise$13.502713,65918,027Apr 29, 2021, 06:33 PM
KKR Iris Investors LLC10% OwnerApr 27, 2021 Option Exercise$13.50118,7121,602,6122,702,638Apr 29, 2021, 05:07 PM
KKR Iris Investors LLC10% OwnerApr 27, 2021 Buy$15.001,100,00016,500,0003,802,638Apr 29, 2021, 05:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Vivo Capital VIII, LLC10% Owner12/19/20232,291
Vivo Capital VIII, LLC10% Owner12/19/202316,693
Vivo Capital VIII, LLC10% Owner12/18/20233,155
Vivo Capital VIII, LLC10% Owner12/18/202322,993
Vivo Capital VIII, LLC10% Owner12/15/20233,499
Vivo Capital VIII, LLC10% Owner12/15/202325,501
Leaman John HaroldChief Fin. & Business Officer12/31/202213,601
SHREWSBURY STEPHEN BChief Medical Officer03/29/202248,474
Hoekman JohnChief Scientific Officer12/22/202132,800
NELSON TIMOTHY SDirector11/19/2021107,554
SHREWSBURY STEPHEN BChief Medical Officer09/21/2021199,720
ADAMS ADRIANCOB, CEO and President08/18/2021279,790
Vivo Capital VIII, LLC10% Owner04/27/20211,369,656
Vivo Capital VIII, LLC10% Owner04/27/20218,625,000
venBio Global Strategic Fund II L.P.10% Owner04/27/20216,750,000
PARKER H STEWARTDirector04/27/20213,659
KKR Iris Investors LLC10% Owner04/27/20211,602,612
KKR Iris Investors LLC10% Owner04/27/202116,500,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR IMPEL PHARMACEUTICALS INC
STOCK BUYBACKS FOR IMPEL PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0%
1Q
09/30/2023
03/31/2023
0.01%
2Q
09/30/2023
12/31/2022
0.03%
3Q
09/30/2023
09/30/2022
0.17%
4Q
09/30/2023
06/30/2022
2.46%
5Q
09/30/2023
03/31/2022
2.62%
6Q
09/30/2023
12/31/2021
62.66%
7Q
09/30/2023
09/30/2021
17.86%
8Q
09/30/2023
06/30/2021
68.20%
9Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0%
1Q
03/31/2023
0.01%
2Q
12/31/2022
0.03%
3Q
09/30/2022
0.17%
4Q
06/30/2022
2.46%
5Q
03/31/2022
2.62%
6Q
12/31/2021
62.66%
7Q
09/30/2021
17.86%
8Q
06/30/2021
68.20%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IMPEL PHARMACEUTICALS INC
LOADING...